Clinical Efficacy and Safety of Injection of Stromal Vascular Fraction Derived from Autologous Adipose Tissues in Systemic Sclerosis Patients with Hand Disability: A Proof-Of-Concept Trial

Clinical Efficacy and Safety of Injection of Stromal Vascular Fraction Derived from Autologous Adipose Tissues in Systemic Sclerosis Patients with Hand Disability: A Proof-Of-Concept Trial

Background: Stromal vascular fraction (SVF) has recently emerged as a potential therapeutic modality, due to its multipotent cellular components in tissue regeneration. Systemic sclerosis (SSc) is a progressive autoimmune disease that results in hand disability by skin fibrosis and microangiopathies...

Full description

Bibliographic Details
Main Authors: Youngjae Park, Yoon Jae Lee, Jung Hee Koh, Jennifer Lee, Hong-Ki Min, Moon Young Kim, Ki Joo Kim, Su Jin Lee, Jong Won Rhie, Wan-Uk Kim, Sung-Hwan Park, Suk-Ho Moon, Seung-Ki Kwok
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Journal of Clinical Medicine
Subjects:
systemic sclerosis
stromal vascular fraction
hand disability
mesenchymal stem cells
clinical trial
Online Access:https://www.mdpi.com/2077-0383/9/9/3023

Internet

https://www.mdpi.com/2077-0383/9/9/3023

Similar Items